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DimerThe homodimeric E5 protein from bovine papillomavirus activates the platelet-derived growth factor β
receptor through transmembrane (TM) helix–helix interactions leading to uncontrolled cell growth. Detailed
structural information for the E5 dimer is essential if we are to uncover its uniquemechanism of action. In vivo
mutagenesis has been used to identify residues in the TM domain critical for dimerization, and we previously
reported that a truncated synthetic E5 peptide forms dimers via TM domain interactions. Here we extend this
work with the ﬁrst application of high-resolution solution-state NMR to the study of the E5 TM domain in SDS
micelles. Using selectively 15N-labelled peptides, we ﬁrst probe sample homogeneity revealing two
predominate species, which we interpret to be monomer and dimer. The equilibrium between the two
states is shown to be dependent on detergent concentration, revealed by intensity shifts between two sets of
peaks in 15N-1H HSQC experiments, highlighting the importance of sample preparation when working with
these types of proteins. This information is used to estimate a free energy of association (ΔGx°=−3.05 kcal
mol−1) for the dimerization of E5 in SDSmicelles. In addition, chemical shift changes have been observed that
indicate a more pronounced change in chemical environment for those residues expected to be at the dimer
interface in vivo versus those that are not. Thus we are able to demonstrate our in vitro dimer is comparable to
that deﬁned in vivo, validating the biological signiﬁcance of our synthetic peptide and providing a solid
foundation upon which to base further structural studies. Using detergent concentration to modulate
oligomeric state and map interfacial residues by NMR could prove useful in the study of other homo-
oligomeric transmembrane proteins.+44 24765 24112.
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At only 44 residues long, the E5 protein from bovine papilloma-
virus type-1 represents the product of the smallest known oncogene
and belongs to a group of proteins known as viral transforming
proteins (VTPs). VTPs stimulate cellular growth pathways leading to
oncogenesis by either mimicking host receptors or constitutively
activating native receptors [1,2]. The E5 protein belongs to the latter
group of VTPs and mainly targets the platelet-derived growth factor
beta receptor (PDGFβR), a cell surface receptor tyrosine kinase [3,4].
E5 is able to partition spontaneously into the plasma membrane
due to a central sequence of hydrophobic residues that fold into a
membrane-spanning α-helix. E5 monomers self-assemble into
homodimers that are thought to interact speciﬁcally with the
transmembrane (TM) domain of PDGFβR [4–6]. This interaction
triggers dimerization of PDGFβR in a manner that is not well-understood, followed by auto-phosphorylation of the cytosolic
domains of PDGFβR and sustained activation of mitogenic activity
[7–9]. Notably, the native activation of PDGFβR involves the binding of
an extracellular ligand; thus the manner in which E5 activates the
receptor via transmembrane domain interactions represents a
completely novel activation mechanism and underlines the need to
develop a greater understanding of the forces governing the helix–
helix interactions between TM domains [10–15].
Despite numerous in vivo and in vitro studies of E5 dimer formation,
the exact interactions that drive its assembly and stabilize the functional
oligomer are still unclear [16–20]. In vivo mutagenesis studies and
computational models have identiﬁed residues in the TM domain of E5
that may play a role in stabilizing the dimer, which has prompted two
models for the assembly of E5 dimers. In one model, the residues A14,
Q17, L21, L24, and F28 are expected to lay at the interface of a
symmetrical dimer with the membrane-embedded residue Q17
possibly forming interhelical hydrogen bonds between E5 monomers
[16,17,20–22]. Thismodel is interesting in that noGXXXG or small-XXX-
small motifs, associated with so many examples of strongly associated
TM helices, are found at the dimer interface. Instead, the dimer is
stabilized by interhelical hydrogen bonding of the polar Gln residue as
Fig. 1. Primary sequence of E5 and synthetic peptides used in this study (E5TM1 and
E5TM2) designed using a molecular model the E5 dimer. (A) In the full-length protein
(E5), residues highlighted in bold are predicted to lie at the dimer interface. Highlighted
residues in E5TM1 and E5TM2 synthetic peptides contain 15N labels on the backbone
amide nitrogen atoms. Lysine residues were incorporated at the termini of the peptides
to increase solubility and aid puriﬁcation. (B) Molecular model for the E5 TM domain
homodimer generated using the CHI program (see Materials and methods), which
illustrates which residues are predicted to lie at the dimer interface. This model was
used to rationalize peptide design. 15N-labelled residues predicted to be at the dimer
interface are shown in space ﬁlling representation, while those residues not expected to
be interfacial are shown in ball and stick.
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homodimer has residues L7, L18, and L25 on one helix packing against
residues V13, V16, and L20 of a second helix to yield an asymmetric
dimer [18]. The transformation activity of E5 can also be blocked by
mutagenesis of a C-terminal cysteine residue, which forms an
interhelical disulﬁde bond in the native protein, and restored by the
addition of a heterologous dimerization domain [17,19,22]. However,
the signiﬁcance of the cysteine residue in driving E5 dimerization was
questioned in a recent biophysical study of E5 that showed a 30-residue
model peptide of theα-helical transmembrane domain formed strongly
interacting homodimers in both detergents and lipid membranes, even
in theabsence of an interhelical disulﬁdebond [23]. Thiswork suggested
that non-covalent lateral interactions between transmembrane helices
are driving initial stages of E5 dimer assembly, which is further
stabilized by disulﬁde bond formation. Importantly, the E5 TM domain
was found to form stable dimers in the detergent sodiumdodecylsulfate
(SDS), suggesting that this is a very strong interaction comparable to
that of the well-characterized TM domain of Glycophorin A [10].
Clariﬁcation of the structural determinants for E5 dimerization and
downstream functionwill likely require high-resolution structural data.
Although structural characterization of hydrophobic membrane pro-
teins suchasE5presents numerous technical challenges in termsof both
protein production and solubilization in NMR-compatible membrane
mimetics, often requiring time-consuming sample optimization steps
[24], there are an increasing number of successful reports in the
literature. In these NMR studies, amphipathic detergents such as
dodecylphosphatidylcholine (DPC), SDS, or lyso-lipids such as lyso 1-
palmitoyl phosphatidylglycerol (LPPG) have been used as membrane
mimetics, with the choice of detergent being greatly assisted by recent
studies, which have systematically evaluated spectral quality versus
detergent type [25,26]. Once an appropriate detergent that yields sharp
and well-dispersed NMR peaks and does not disrupt important protein
interactions has been found, solution NMR has been used very
effectively to obtain structural information for small hydrophobic
peptides that self-associate [27–32].
In order to progress toward amore detailed structural understanding
of the E5 homodimer, we have analyzed two detergent-solubilized
selectively labelled synthetic peptides using solution-state NMR. We
demonstrate the critical role the peptide-to-detergent ratio plays in
controllingdimerization andexploit this relationship to identify residues
that lie at the helix–helix interface. Our data were ﬁt to an equation
representing a monomer–dimer equilibrium and used to estimate a
standard free energy of association. Our results support a symmetrical
model of the E5 dimer that contains Ala14, Gln17, Leu21, Leu24, and
Phe28 at the dimer interface. This model is in agreement with in vivo
studies and provides theﬁrst evidence that our in vitro dimer interface is
comparable to that deﬁned in vivo, thus validating the biological
signiﬁcance of our synthetic peptide and providing a solid foundation
upon which to base further structural studies and the de novo design of
proteins exploiting the unique mechanism of action employed by E5.
2. Materials and methods
2.1. Peptide synthesis and puriﬁcation
Two selectively 15N-labelled peptides corresponding to the TM
domain of E5 (E5TM1 and E5TM2, see Fig. 1A) were synthesized at the
Keck Facility at Yale University using F-moc chemistry. The sequences of
both peptides were identical except that they contained isotopic labels
at different positions. Both E5TM peptides also contained non-native
lysine residues to aid solubility and end caps on the C- and N- termini.
The peptides were puriﬁed by reversed-phase HPLC (RP-HPLC) using a
linear acetonitrile gradient including 0.1% triﬂuoroacetic acid (TFA)
(Sigma-Aldrich, UK) on a Phenomenex C4 column (Phenomenex, UK).
The purity of fractionswas conﬁrmed byMALDI-TOFmass spectrometry
before fractions were pooled and lyophilized.2.2. Sample preparation for NMR analyses
For spectra of E5 acquired in organic solvent, lyophilized peptides
were solubilized in an 80:20 v/v mixture of deuterated triﬂuoroethanol
(d3-TFE): H2O to a ﬁnal peptide concentration of 0.5 mM. Detergent
solubilized samples were prepared by ﬁrst dissolving peptides in
triﬂuoroethanol (TFE) (Sigma-Aldrich, UK) and then adding this solution
to an aqueous solution of deuterated sodium dodecylsulfate (SDS-d25)
detergentmicelles (Cambridge Isotope Laboratories, Andover,MA),with
the volume of TFE kept minimal to prevent precipitation of the
detergent. The peptide-detergent solution was then lyophilized to
remove the TFE, resuspended in 20 mM sodium phosphate buffer
(pH 5.8) containing 10% D2O using a vortex mixer, sonicated at 40 °C
for 15–30 min, and allowed to equilibrate for 24 h before spectra
were acquired. The peptide concentration was kept at approximately
700 µM, while the concentration of SDS detergent was incrementally
increased to yield peptide:micellar detergent molar ratios between
0.0014−0.0318 for E5TM1 and 0.001−0.0412 for E5TM2 (assuming a
critical micelle concentration for SDS of 9 mM [33]).
2.3. NMR spectroscopy
Sensitivity-enhanced 2D 1H–15N HSQC spectra were acquired at
40 °C on either a 500 or 700 MHz Bruker Avance spectrometer ﬁtted
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et al. [34]. The spectra were recorded with 128 increments in the t1
dimension and 2K real points in the t2 dimension. The sweep width
was 13 ppm in the proton dimension. Spectra were processed using
Topspin 2.0 and analyzed with CcpNMR analysis software [35].
Backbone amide proton and nitrogen chemical shift assignments of
the E5TM peptides were obtained from 1H–15N HSQC–TOCSY spectra
with a spin-lock duration of 60 ms and 1H–15N HSQC–NOESY spectra
with mixing times of 60−100 ms, using the pulse sequences
described by Schleucher et al. [34,36]. In both the TOCSY and the
NOESY spectra, the sweep width was 13 ppm in both dimensions.
Average backbone amide chemical shift differences (Δδ) were
calculated according to Eq. (1) below [37]:
Δδ = ΔδHNð Þ2 +
ΔδN
5
 2 0:5
ð1Þ
where ΔδHN and ΔδN are the chemical shift differences between
monomeric and dimeric species for the amide proton and nitrogen
atoms, respectively.
The strength of dimerization of the E5TM1 peptide in SDS detergent
micelles was estimated by acquiring a series of 1H–15N HSQC spectra
for samples prepared with decreasing peptide:micellar detergent
molar ratios (see above) and determining the peak volumes for the
momomer and dimer peaks of all the labelled residues. The peak
volumes were then used to estimate the fraction dimer present (fD),
and this was plotted against the peptide:micellar detergent molar
ratio in order to determine the association constant (KX) using an
approach adapted from previous reports [37,38] as outlined below.
Consider the reaction
M + M⇌M2
where M denotes a monomer and M2 denotes a dimer. Fleming [38]
proposes the following approximation for the association equilibrium
constant:
KX =
νD = 2ð ÞQpep =Qmic:SDS
1−νDð ÞQpep =Qmic:SDS
 2 ð2Þ
where vD is the fraction of peptide present as dimer, Qpep is the quantity
of peptidepresent in either form, andQmic.SDS is thequantity of detergent
present as micelles; this approximation assumes Qmic.SDS≫Qpep. The
NMR data yield an estimate of vD:
vD =
ID
ID + IM
ð3Þ
where ID and IM are the integrals of the dimer andmonomer peaks in the
NMR spectrum, respectively. The fraction dimer in the micellar phase is
given by
fD = νD = 2ð ÞQpep
 
= νD = 2ð ÞQpep + 1−νDð ÞQpep
 
= νD = 2−νDð Þ:

ð4Þ
Now, assuming the activity of SDS γSDS=1 (ideal solution conditions):
1
KX
=
1−vDð Þ2
vD = 2
⋅
Qpep
Qmic:SDS
= 2
1−vDð Þ2
vD
⋅
peptide½ 
mic:SDS½  ð5Þ
where square brackets indicate bulk concentrations. This yields:
fD =
1 + 2KX peptide½ = mic:SDS½ −
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 + 8KX peptide½ = mic:SDS½ 
p
2 KX peptide½ = mic:SDS½ −1ð Þ
:
ð6ÞNon-linear least-squares ﬁtting of this equation gives an estimate of KX,
which is related to the standard free energy change by ΔGX° =−RT ln
KX where T is the temperature in K and R is the universal gas constant
(cal K−1 mol−1).
2.4. Circular dichroism (CD) spectroscopy
Lyophilized peptides (40 μM) were solubilized in increasing
concentrations of SDS detergent to yield peptide:micellar detergent
molar ratios ranging from 8×10−4 to 0.04, thus spanning the entire
range of those used in NMR experiments. CD experiments were
carried out using a Jasco J715 spectropolarimeter (Jasco UK, Great
Dunmow, UK) and 1-mm path-length quartz cuvettes (Starna;
Optiglass Ltd., Hainault, UK). Spectra were recorded between 190
and 260 nm with a data pitch of 0.2 nm, a bandwidth of 2 nm, a
scanning speed of 100 nm min−1, and a response time of 1 s. Data
shown were averaged from four individual spectra and measurement
of the buffered detergent solution without peptide was subtracted to
obtain the ﬁnal spectra.
2.5. SDS-polyacrylamide gel electrophoresis (PAGE)
The E5TM1 peptide was prepared for electrophoresis by dissolving
increasing amounts of peptide (ranging from 1.8 to 63.6 μM) in 20 mM
sodium phosphate buffer (pH 5.8) containing 10 mM SDS to achieve
peptide:micellar detergentmolar ratios ranging from8.8×10−4 to 0.03,
again spanning the entire range used in NMR and CD experiments.
Samples were loaded on a 12% NuPAGE Bis–tris gel (Invitrogen)
according to manufacturers' guidelines. Peptide visualization was
achieved by staining with Coomassie-R250 (shown for p:m=0.032–
0.006) and silver nitrate (shown for p:m=0.005–8.8×10−4).
2.6. Computational models of the E5 homodimer and E5-PDGFβR TM
interactions
Structural calculations for the E5 homodimer were carried out using
theCNS searchingof helix interactions (CHI) software [39], on an8-node
dual 2.66 GHz Xenon processor Linux cluster (Streamline computing,
Warwick, UK). E5 dimer models were calculated containing residues
8–34 from thewild-type protein. Starting geometries incorporated both
left- and right-handed crossing angles of 25° with a distance of 10.4–
11.0 Å between the helices. Full searches of the dimer were carried out
by rotating each helix around its central axis through 360° in 45°
increments, followed by simulated annealing and energyminimization.
Clusters of 10 or more structures with a backbone RMSD of b1 Å were
created, and an average structure was calculated for each cluster.
Computational models of potential E5-PDGFβR TM domain interactions
were created using the 3D-Dock suite of programs [40] to analyze
interaction of the E5 homodimer model (Fig. 1B) with a model of the
helical PDGFβR TM domain containing residues K499-W524. Con-
straints were applied in the FTDock program to ﬁlter out all results in
which Gln17 (in E5) was more than 5 Å from Thr513 (in PDGFR) or in
which Asp33 (in E5)wasmore than 5 Å from Lys499 (in PDGFβR), since
these interactions have been shown to stabilize the interaction in vivo
[1]. Side-chain reﬁnement of the remaining models was carried out
using Multidock [41] with a dielectric constant of 2.0, and the results
were analyzed using PyMOL version 0.99.
3. Results
It was previously shown that a synthetic peptide derived from the
E5 TM domain self-associates to form a homodimer in detergent
solution [23]. The strategy of studying synthetic peptide analogues is
highly advantageous for NMR spectroscopy studies since it allows
NMR-active isotopes to be incorporated at speciﬁc positions. In this
study, two peptides containing residues F9 to H34 of wild-type E5
Fig. 3. 15N-edited 1H-1H TOCSY spectra acquired on a Bruker 700 MHz instrument for
the E5TM1 peptide solubilized in 80% TFE-d3/20% H2O. Assignments are shown on the
spectrum and were made with reference to known resonance patterns and tables of
chemical shifts.
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sequences of both peptides were truncated relative to the full-length
E5 protein to include only the TM domain, and lysine residues were
incorporated at the N- and C-termini as described previously [23].
Each of these peptides contained different combinations of 15N-
labelled amino acids. The ﬁrst peptide (E5TM1 in Fig. 1A) contained
15N-labelled amino acids at positions predicted to lie at the dimer
interface (i.e., Ala14, Leu21, and Phe28). As a control, a second peptide
was synthesized (E5TM2; Fig. 1A), which contained 15N-labelled amino
acids at positions predicted to lie within (Ala14 and Leu24) and
outside of (Gly11, Val13, Leu19, and Val30) the predicted dimer
interface [17]. A molecular model for the E5 TM domain dimer
generated using the CHI program [39] (see Materials and methods) is
shown in Fig. 1B and was used for rational peptide design and aiding
interpretation of results.
3.1. Characterization of E5 peptides in triﬂouroethanol
Initial characterization of the selectively labelled E5TM1 and E5TM2
peptides was carried out in 80:20 v/v deuterated triﬂuoroethanol
(TFE-d3): H2O. Although TFE promotes secondary structure formation
for these hydrophobic peptides, it destabilizes intermolecular helix–
helix interactions [42] and disrupts oligomer formation. Therefore,
under these conditions, it was expected that E5 should be monomeric
and highly α-helical. The correct labelling of the peptides was
conﬁrmed by acquiring a 2D heteronuclear single quantum coherence
spectrum (15N-1H HSQC), which enables resonances from 15N-
labelled amide groups to be observed. As shown in Fig. 2A (red
peaks), the expected three resonances were observed for the E5TM1
peptide, indicating that the labelling was successful and that the
peptide adopted a single conformation (i.e., a monomeric helix).
Similarly, a 15N-1H HSQC spectrum of the E5TM2 peptide revealed the
expected six resonances, as shown in Fig. 2B (red peaks). All of the
resonances for both peptides were assigned via 3D 15N-edited HSQC-
TOCSY experiments, with representative spectra for E5TM1 and E5TM2
shown in Figs. 3 and 4, respectively. The chemical shifts are listed in
Table 1. For E5TM2, we were not able to unambiguously assign L19 and
V30 due to spectral overlap, so these resonances were assigned to
either residue (labelled L/V or L19/V30).
3.2. Two conformations of E5 are observed in SDS detergent micelles
Although solubilizing E5TM peptides in TFE/H2O produced samples
amenable for NMR analyses (i.e. narrow peaks and a homogeneous
population), this solvent system is considered a poor mimic of aFig. 2. 15N-1HHSQCspectra acquiredon a Bruker 700MHz instrument for (A)E5TM1 and (B) E5TM
For spectra acquired in TFE, the number of resonances observed corresponds to thenumber of 15N
SDS, indicating the presence of two species. All peaks in the spectra have been assigned as indi
rotameric form of one of the Leu residues, but more data are required to conﬁrm this. A similarmembrane bilayer. To investigate the structural features of E5 in an
environment more akin to an amphipathic membrane, the peptides
were solubilized in detergent micelles. The detergent sodium
dodecylsulfate (SDS) was selected since it has been shown to
solubilize E5 and not disrupt dimer formation by SDS-PAGE [23].
Previous reports have also shown the applicability of SDS for NMR
studies [30,43], and a very recent study has suggested that SDS can
reasonably preserve the tertiary structures of membrane proteins
with small extramembranous segments (such as that under investi-
gation here) [44]. Initially, 1H–15N HSQC spectra were acquired for
samples of E5TM1 peptide dissolved in 50 mM SDS, and resonance
assignments were made using 1H–15N HSQC-TOCSY and 1H–15N
HSQC-NOESY experiments (data not shown, assignments are given in
Table 1). Comparison of the 2D HSQC spectrum of the E5TM1 peptide
acquired in SDS to that acquired in TFE (see black spectrum in Fig. 2A)
demonstrates that the relative position of the resonances with respect
to one another does not signiﬁcantly change upon solubilization in
SDS micelles. However, as expected, the peak widths are increased in
spectra acquired in SDS micelles, due to the slower tumbling of the
larger peptide–micelle complex. A more notable difference between2 peptides solubilized in80%TFE-d3/20%H2O (red spectra) and50 mMSDS (black spectra).
-labelled residues in thepeptides. A doubling of all peaks is observed in spectra acquired in
cated, apart from one peak labelled with an asterisk (*). This peak may be due to a second
peak is seen for Leu 21 in Fig. 6. The assignments for all peaks can be found in Table 1.
Fig. 4. 15N-edited 1H-1H TOCSY spectrum acquired on a Bruker 700 MHz instrument for
the E5TM2 peptide solubilized in 80% TFE-d3/20% H2O. Assignments are shown on the
spectrum and were made with reference to known resonance patterns and tables of
chemical shifts.
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SDS was greater than the number of labelled residues by a factor of
two. In SDS, doubling of each of the three resonances yielded two sets
of resonances, with each resonance pair being separated by a fraction
of a ppm. The two sets of resonances were attributed to the presence
of two E5 species that were in slow exchange on the NMR time scale.
The small chemical shift difference between the two sets of
resonances suggested these two species are structurally similar. This
resonance doubling was also observed in spectra of the E5TM2 peptide
dissolved in SDS (Fig. 2B; black spectrum) and has been observed in
previous NMR studies of TM domain oligomers [37,45] where it was
attributed to the presence of different oligomeric states (each one
giving rise to a set of peaks in the NMR spectrum). These reports,
along with our previous data supporting the formation of dimers by
this peptide sequence [23], lead us to provisionally attribute the two
sets of observed peaks to two oligomeric forms of the E5 TM domain.
3.3. Conformations of E5 peptides are modulated by detergent
concentration, but secondary structure is not
If the two distinct species observed for the detergent-solubilized
E5 peptides were due to two oligomeric states, then little change inTable 1
Chemical shift assignments (in units of ppm) for E5TM1 and E5TM2 in TFE and SDS micelles.
Chemical shifts in TFE (ppm) C
N NH αH βH N
E5TM1 peptide
Ala14 120.44 8.30 4.31 1.69 1
Leu21 118.50 8.08 4.36 2.10 1
Phe28 118.26 8.62 4.53 3.54 1
E5TM2 peptide
Gly11 103.97 7.99 3.98 1
Val13 118.92 7.97 3.76 2.24 1
Ala14 121.00 8.31 4.25 1.66 1
Leu24 118.23 8.63 3.91 2.25 1
Leu19/Val30b 120.41 8.66 4.35 2.24 1
118.81 8.22 4.25 2.10, 1.81 1
a The ﬁrst number represents the chemical shift for the monomeric form of E5, while the
b Leu19/Val30N/A is not speciﬁcally assigned due to ambiguity/spectral overlap.the secondary structure of the peptide would be expected (i.e., the
peptides should remain predominantly α-helical at detergent con-
centrations in the range used for NMR experiments). However, the
two species may also have very different secondary structures, such as
aggregated peptide (β-sheet) and fully solubilized peptide (α-helix).
In this case, one would expect to observe changes in the secondary
structure as the detergent concentration is increased. Circular
dichroism (CD) spectra acquired for the E5TM1 peptide at peptide:
micellar SDSmolar ratios ranging from 8×10−4 to 0.04 (see Materials
and methods) suggest that the former is most likely, as the CD spectra
at all concentrations of SDS tested show a characteristic α-helical
proﬁle with negative absorptionmaxima at 208 and 222 nm (Fig. 5A).
Analysis of the data using CDSSTR software [46] indicates that the
peptide is approximately 83% α-helical. Signiﬁcantly, no substantial
differences in helicity were observed upon varying the [peptide]:
[micellar SDS] ratio over the range used in the NMR studies. Similar
results were obtained for E5TM2 (data not shown). These data
demonstrate that the E5TM peptides form very stable α-helices at all
concentrations of SDS studied and strongly suggest that the two sets
of resonances observed in the NMR spectra both originate from highly
α-helical species. Notably, similar observations have been made by
Wu et al. for the TM domain of the major coat protein from Ff
bacteriophage [37].
With this in mind, the effect of detergent concentration on the
population of each helical species was then tested, since it is well
established that the peptide:micellar detergent molar ratio can
modulate helix–helix interactions and thus the oligomeric states of
transmembrane domains without affecting the helicity of TM domain
segments [47–49]. HSQC spectra were acquired for samples contain-
ing a range of peptide:micellar SDS ratios that would complement the
CD studies described above (see Materials and methods). As shown in
Fig. 6A, at the lowest SDS concentration tested (30 mM) the 1H–15N
HSQC spectrum of the E5TM1 peptide displays only three major peaks,
which would be expected for a homogeneous population of E5
peptides with three 15N-labelled residues. Upon increasing the
detergent concentration, a second set of three peaks appeared,
which steadily increased in intensity while the original set of peaks
decreased in intensity (Fig. 6B). These data again indicate the
presence of two species in slow exchange on the NMR time scale.
Increasing proportions of monomeric E5 would be expected at the
highest detergent concentrations, possibly via competition of SDS
detergent molecules for the interfacial region of E5 monomers, while
a higher population of oligomers would be expected at lower
detergent concentrations [47–49]. Since higher order oligomers
than dimer have not been observed by us for E5, it seems most likely
that the two sets of resonances arise from dimeric (D) andmonomeric
(M) species of E5TM1 as indicated in Fig. 6. This is supported by SDS-
PAGE analysis of the E5TM1 peptide (Fig. 5B) prepared at peptide:hemical shifts in SDSa (ppm) Δδ
NH αH βH
21.36 (121.22)a 8.39 (8.28) (3.98) (1.46) 0.11
18.90 (118.45) 8.08 (8.00) (3.99) (1.79) 0.12
18.88 (118.55) 8.87 (8.74) (4.17) (3.24) 0.15
05.33 (105.33)a 8.36 (8.31) 0.05
17.69 (117.63) 8.02 (7.97) 0.05
21.27 (121.72) 8.42 (8.36) 0.11
18.46 (117.69) 8.43 (8.42) 0.15
19.40 (119.25) 8.67 (8.60) 0.08
18.27 (118.27) 8.19 (8.16) 0.03
number in parentheses is the chemical shift for the dimeric form.
Fig. 6. HSQC spectra of E5TM1 in SDS detergent, demonstrating modulation of two
species with changes in detergent concentration. (A) Stacked 2D contour plots from
15N-1H HSQC spectra of E5TM1 as a function of SDS detergent concentration. Residue
assignments are indicated at the top of the plot, and the set of peaks attributed to
monomer (M) and dimer (D) are indicated. It can be seen that monomer dominates at
high detergent concentration, while dimer is the primary species at low detergent
concentration (as expected). (B) 1D projections of planes from 2D HSQC spectra that
more clearly illustrate the changes in the relative intensities of monomer and dimer (D)
peaks with changes in detergent concentration. The peak marked with an asterisk (*) is
thought to be due to a second rotameric form of Leu 21 present at low detergent
concentrations.
Fig. 5. Secondary structure and oligomeric state of E5 peptide dissolved in a variety of
detergent concentrations. (A) Circular dichroism spectra of the E5TM1 peptide
reconstituted in SDS micelles at [peptide]:[micellar SDS] molar ratios ranging from
8×10−4 (bold solid line) to 0.043 (bold dotted line). Spectra are also shown for four
intermediate [peptide]:[micellar SDS] molar ratios (0.0038, 0.0031, 0.0025, 0.0012, thin
solid lines), which almost exactly overlay one another at wavelengths above 200 nm.
Data are given in units of mean residue ellipticity (MRE, mdeg cm2 dmol−1). (B) SDS-
PAGE analysis of E5TM1 peptide dissolved in SDS micelles at [peptide]:[micellar SDS]
molar ratios ranging from 9×10−4 to 0.03. At the four highest peptide concentrations
analyzed (shown for p:m=0.032–0.006), peptide was visualized by staining with
Coomassie-R250. At the lower peptide concentrations, silver nitrate was required to
resolve bands. In all lanes, only bands corresponding to monomer and dimer are
observed (see Oates et al. [23] for discussion of band identiﬁcation [23]).
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NMR. At every molar ratio, only bands corresponding to the monomer
and dimer species are observed (see Oates et al. for band identiﬁcation
[23]). However, it should be noted that the relative populations of
monomer and dimer are very different in the two experiments, with a
much larger population of dimer at the highest SDS concentrations
being observed in SDS-PAGE gels. This may be due to changes in the
SDS concentration (depletion/enrichment) as the protein migrates
down the gel, resulting in a new (and possibly quite similar) SDS
concentration in each lane.
Adding further support to the hypothesis that E5 exists in a
monomer–dimer equilibrium under NMR conditions is the presence
of a minor peak observed for Leu21 (predicted to lie at the helix–helix
interface of the E5 dimer) at the lowest micelle concentration (see *,Fig. 6B). This may be due to close packing of the helices in the dimer
interface restricting the motion of the Leu side chain, causing it to
adopt different rotameric forms. Rotamers of Leu side chains at closely
packed dimer interfaces have been observed previously for other
transmembrane domain dimers [50]. It is conceivable that this leads
to small changes in the chemical environment of the backbone amide
group and hence results in a small change in the chemical shift. This
interpretation is consistent with the fact that the Leu21 multiplet
1499G. King et al. / Biochimica et Biophysica Acta 1808 (2011) 1493–1501resolves to a single peak as the detergent concentration is increased
and E5 presumably becomes more monomeric, which would release
the Leu side chain from steric restrictions at the interface.
The peak volumes from both sets of resonances observed in the
1H–15N HSQC spectra shown in Fig. 6 were then used to determine the
strength of dimerization for the E5TM1 peptide in SDS micelles. The
fraction of peptide present as dimer (vD) was estimated from peak
volumes using Eq. (3) and used to calculate fD (see Eq. (4)). Values for
fD are plotted against the [peptide]:[micellar SDS] molar ratio as
shown in Fig. 7. Independent values of fD were calculated for each of
the three amino acids (Ala14, Leu21, Phe28), and the three values are
plotted separately on the graph. The graph also shows the non-linear
least squares ﬁt of Eq. (6) to the data (thick black line), which
corresponds to a monomer–dimer equilibrium with a KX=136 and
ΔGX°=−3.05 kcal mol−1. To assess the uncertainty in the ﬁt, a range
of curves for values between KX=75 and 250 (thin lines, bottom to
top, increments of 25) is shown; these correspond to standard
free energy changes between ΔGX°=−3.43 and −2.68 kcal mol−1
(or±12.5%). As mentioned in previous studies [37,38], these values
are likely to overestimate the true interaction energy as they assume
ideal solution conditions that are not likely at the high peptide and SDS
concentrationsused in this study.While themagnitude andmechanistic
basis of this effect are not known, we have attempted to account for
crowding effects at higher peptide:SDS ratios by introducing a generic
correction factor. We modiﬁed the model such that KX is multiplied by
the empirical correction factor (1+(ρ[pep]/[mic. SDS])β), which
introduces a dependence of KX on the [pep]/[mic. SDS] ratio. As an ab
initio treatment of the crowding effect poses formidable challenges, we
used an ad hoc formula that slightly generalizes the cubed dependence
of Enskog theory; ρ is a scale parameter, where the association constant
is doubled when there are 1/ρ peptide molecules per micellar SDS
molecule and β is an exponent that indicates the rate of increase with
the crowding effect. The least-squares ﬁt of this model to the data is
shown in Fig. 7 (grey line) and reports estimates of KX=105 (ρ=33.7,
β=4.41), andΔGX°=−2.89 kcalmol−1, thus supporting the suggestion
that extrapolating from dilute solution substantially overestimates the
true KX.
Similar to the analyses of the E5TM1 peptide, 1H–15N HSQC spectra
were also acquired for the E5TM2 peptide prepared with comparable
peptide:micellar SDS ratios. The spectra also revealed two sets ofFig. 7.Non-linear least squares ﬁtting of NMR data to obtain estimate of E5 dimerization
afﬁnity in SDS micelles. Peak volumes from 1H–15N HSQC spectra shown in Fig. 6 were
used to estimate the fraction dimer present (fD, see Materials and methods), and these
values were plotted against the [peptide]:[micellar SDS] molar ratio for Ala14 (Ο),
Leu21 (Δ), and Phe28 (□). Non-linear least-squares ﬁtting of the data to Eq. (6) (thick
black line) resulted in a value for KX=136 and ΔGX°=−3.05 kcal mol−1. The
uncertainty in the ﬁt was assessed by plotting a range of curves for values between
KX=75 and 250 (thin lines, bottom to top, increments of 25). These lines correspond to
standard free energy changes between ΔGX°=−3.43 and −2.68 kcal mol−1. The thick
grey line is a non-linear least squares ﬁt of a version of the model that includes an
empirical correction factor (see Results). This ﬁt leads to an estimate of KX=105 and
ΔGX°=−2.89 kcal mol−1.resonances for the labelled residues (see Fig. 2B), with the relative
intensities of these two sets being modulated by increasing detergent
concentration (data not shown) in a similar manner to the E5TM1
peptide. These peaks were therefore assigned to monomer and dimer
forms of the E5TM2 peptide. However, given that the E5TM2 peptide
contained labelled residues situated inside and outside of the
predicted dimer interface (as opposed to the E5TM1 peptide, which
only contained 15N-labelled residues at predicted interfacial posi-
tions), we were surprised to see that residues predicted to lie on the
surface of the dimer (i.e. non-interfacial) were experiencing two
distinct chemical environments as the detergent concentration was
changed. To determine if those residues expected to participate in
direct protein–protein interactions (i.e., interfacial residues) experi-
enced a greater change in chemical environment, quantitative
analyses of the chemical shift differences between the resonances
from the two species were undertaken as described by Wu et al. [37].
3.4. Ala14, Leu21, Leu24, and Phe28 lie at the dimer interface of the
E5TM peptide in SDS detergent micelles
It has been reported that the average difference in backbone amide
chemical shifts as calculated from a 15N–1H HSQC spectrum can be
used to identify interfacial residues in oligomers, since resonances
from interfacial residues should, in theory, undergo a more signiﬁcant
shift upon oligomer formation than those of other residues in the helix
due to their signiﬁcantly altered chemical environment [37]. This
approach was used here to explore whether the chemical shift
differences between the putative monomer and dimer resonances of
the E5 TMdomain could help identify the residues that lie at the dimer
interface. The average backbone amide chemical shift differences (Δδ)
for the assigned resonances of E5TM1 and E5TM2 were calculated as
described by Eq. (1) [37] and are listed in Table 1. The greatest average
differences were observed for those residues in the helix predicted to
lie at the dimer interface, namely Ala14 (Δδ=0.11), Leu21 (0.12),
Leu24 (0.15), and Phe28 (0.15). These residues showed a two- to
threefold increase in chemical shift difference values when compared
to residues predicted to lie outside of the interface such as Gly11 and
Val13 (Δδ=0.05) and Leu19/Val30 (Δδ=0.03/0.08), demonstrating
that they experience a larger change in chemical environment when
moving from one species to another.
These data also indicate that the value for Δδ contains a
contribution that is not due to direct protein–protein interactions,
since residues outside the predicted dimer interface were also
sensitive to changes in detergent concentration. We suggest that the
value for Δδ in the presence of detergent micelles may be best
expressed as:
Δδobs = ΔδDimer + ΔδEnv
where ΔδObs is the observed value of Δδ, δDimer is the contribution
from protein–protein interactions at the dimer interface, and ΔδEnv is
the contribution of other environmental factors. Although our data
cannot identify the origin of the ΔδEnv term, we suggest that it may
result from (i) small changes in the protein backbone along the length
of the peptide upon oligomerization or (ii) different micellar
environments (different protein−detergent interactions) for mono-
mers and higher order oligomers.
4. Discussion
In order to better understand the structure and assembly of the
virally encoded E5 protein, we have performed the ﬁrst application of
high-resolution solution-state NMR techniques to study the E5
transmembrane domain homodimer using model peptides and
detergent micelles. Our data demonstrate that, in NMR-compatible
membrane mimetics, the E5 TM domain adopts two structurally
Fig. 8. Inspection of residues on the surface of the E5 dimer and potential PDGFβR TM
domain bindingmodes. (A) Helical wheel representation of left-handed coiled–coil dimer
of E5 TMdomain,with surface-exposed residues highlighted in bold that havebeen shown
be important for productive interactions with the receptor in E5 point mutants and
retroviral libraries where Gln17 was maintained (Leu25, Leu29, and D33). (B) Model of a
chemically plausible interaction between the E5 dimer and the PDGFβR TM domain (see
Materials andmethods for details) thatﬁts thedata presentedhereandproduces favorable
packing/electrostatic interactions between Leu25, Leu29, and D33 on the surface of the E5
dimer with residues in the receptor known to be required for interactionwith E5 (namely
K499, I506, T513, and L520).
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monomeric and dimeric forms. We were able to modulate the relative
concentrations of these two oligomeric forms (while maintaining α-
helical secondary structure) by varying the detergent concentration,
and used these data to estimate a standard free energy for E5
dimerization in SDS detergent of approximately −3.05 kcal mol−1.
This value is in reasonable agreement with published values for other
TM helical dimers measured in SDS micelles, such as the TM domain of
Ff bacteriophage major coat protein (−3.4 kcal mol−1) [37] and
gycophorin A (−4.48 kcal mol−1) [38]. However, this interaction is
much weaker than the previously measured dimerization of the E5 TM
domain in dodecylphosphocholine (DPC) micelles (−5.0 kcal mol−1)
[23], likely due to the different chemical environments of SDS and DPC
micelles. As mentioned by Wu and co-workers [37], the standard
interaction energy is speciﬁc to a given detergent, and SDS micelles are
highly negatively charged and considered to be strongly denaturing
when compared to milder zwitterionic DPC micelles. We suggest that
this could contribute to the pronounced shift in the apparent dis-
sociation constant. Nonetheless, the data acquired in SDS ﬁt well to a
model describing amonomer–dimer equilibrium, andwhen considered
with previous data in DPC micelles and lipid membranes, clearly
demonstrates the speciﬁc dimerization of the E5 TM domain in a range
of environments.
In addition, our data provide more detailed information on the
structure of the dimer. Speciﬁcally, we show that residues in the E5
TM domain previously predicted to be involved in key protein–
protein interactions that stabilize the functional dimer (Ala14, Leu21,
Leu24, and Phe28) displayed an increased backbone amide chemical
shift change relative to those residues not expected to be involved
(Gly11 and Val13). Mapping of these residues onto a structural model
of the E5 dimer is wholly consistent with a symmetrical model for the
E5 homodimer (Fig. 1B) proposed previously from in vivo mutagen-
esis studies [17,21], molecular dynamics simulation [16], and our own
low-resolution biophysical investigations [23]. These results not only
validate that our detergent-solubilized, synthetic, truncated E5
peptide is forming very similar secondary and tertiary structure to
that observed in vivo for the wild-type protein, thus supporting the
biological signiﬁcance of our synthetic peptide approach, but also
provides a solid foundation upon which to base further structural
studies. Furthermore, the results reinforce the relevance of studying
protein–protein interactions that occur within the membrane bilayer,
since these regions are central in understanding the mechanism via
which this oncoprotein functions. Using detergent concentration to
modulate oligomeric state and map interfacial residues by NMR could
prove useful in the study of other homo-oligomeric transmembrane
proteins.
Along with the residues at the dimer interface, it is also interesting
to note the residues that are exposed on the surface of the E5 dimer, as
these would be the most likely points of contact with the PDGFβR TM
domain. These include Leu25, Leu29, and D33 (Fig. 8A, bold), all of
which were shown to be important for productive interactions with
the receptor in E5 point mutants [51] or in retroviral libraries where
Gln17 was maintained [17]. Computational analyses of this E5 dimer
model with a model of the helical PDGFβR TM domain (Fig. 8B, see
Materials andmethods for details) produces a favorable orientation for
potential packing/electrostatic interactions between Leu25, Leu29,
and D33 on the surface of the E5 dimer with residues in the receptor
known to be required for interaction with E5 (namely K499, I506,
T513, and L520) [52]. Of course, much more work is required to
conﬁrm or reject this model, but it is mentioned here as an example of
a chemically plausible E5–PDGFβR interaction that takes into account
well-known interactionmotifs andﬁts the datawehave obtainedhere.
Because E5 is such a highly biologically active peptide, it is
currently being used as a template for the design and screening of
proteins that can selectively bind and activate cellular receptors such
as the PDGFβ receptor [20,53] and the human erythropoietin receptor[54]. This approach has huge potential in the development of novel
therapeutics that target membrane proteins. Many of the studies
mentioned above have used retrovirus library construction to create
and screen large numbers of sequences for biological activity. These
techniques have provided large amounts of information on the rules
that govern TM helix–helix interactions. It is our hope that continued
efforts to elucidate the three-dimensional structural features of these
strongly interacting systems will provide the detail needed to fully
deﬁne the basic mechanisms of interaction, and thus an improved
ability to exploit TM helices.
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